Quality of life in asthma and COPD: Is it measurable in primary care?

Maura Carone, Fabio Arpinelli, Andrea Pieretto, Roberta Tosatto, Gaetano Caramori, Giorgio Bertolotti, Germano Bettoncelli

Research output: Contribution to journalArticle

Abstract

Background. An observational cross-sectional study under the acronym CORDIS (Chronic Obstructive Respiratory Disease - Italian Study), performed in primary care centers to evaluate the knowledge and the degree of control of physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD) by Italian General Practitioners (GPs). The study consisted of two phases, CORDIS-A and CORDIS-B. The CORDIS-B study included measurement of the quality of life (QoL) of physician-diagnosed asthma and COPD patients. Aim. Aim of the study was to evaluate the applicability of QoL assessment by means of the SF-12 Questionnaire in primary care in subjects with asthma or COPD. Secondary, to evaluate the impact of the two respiratory diseases on patients' QoL and to measure the correlation between patients' and GPs' opinion on patients' health status. Methods. Patients enrolled in the study were males and females aged more than 18 years, with a physician (GP or specialist) diagnosis of asthma and/or COPD and treated from at least 12 months with a short-term inhaled β 2-agonist, given alone or as component of a multiple therapy. Patients gave written informed consent to participate to the study and for personal data use. Each patient enrolled in the study privately filled in the QoL SF-12 questionnaire; both the patient and the GP gave independently the judgement of patient's health (Excellent, Very good, Good, Acceptable, Poor) and the two opinions were compared. Results. Complete QoL data were available for 11,642 subjects with a mean age of 57 ± 17 years and a prevalence of males of 55.3%. The percentage of patients with asthma, COPD, and asthma plus COPD was 47.2%, 29.2% and 23.6%, respectively. At least one concomitant disease was present in 67% of patients. In terms of evaluation of patient's health status, a perfect concordance between the two types of evaluators was found in 54.6%; the percentage increased up to 95% when considering just one category of difference between the GP's and the patient's evaluation. As for the general Italian population, no substantial gender difference was found in our study for the SF-12 "Physical Component Summary" (PCS) and "Mental Component Summary" (MCS) mean scores. However, the CORDIS-B subjects showed more impaired health status in comparison to general population. Asthmatic patients showed better PCS and MCS scores in comparison to patients with COPD or asthma plus COPD (p <0.0001). Conclusions. This study shows that a) the SF-12 Questionnaire is a simple and useful tool to measure the QoL of patients with asthma and COPD in primary care; b) there was a very good agreement in the subjective evaluation of the patient's health status between GP and patient; c) mental/psychological component is underestimated both by GP and patient.

Original languageEnglish
Pages (from-to)220-226
Number of pages7
JournalRassegna di Patologia dell'Apparato Respiratorio
Volume24
Issue number4
Publication statusPublished - Aug 2009

Fingerprint

Chronic Obstructive Pulmonary Disease
Primary Health Care
Asthma
Quality of Life
General Practitioners
Health Status
Physicians
Informed Consent
Population

Keywords

  • Asthma
  • COPD
  • Quality of life
  • SF-12 questionnaire

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine

Cite this

Carone, M., Arpinelli, F., Pieretto, A., Tosatto, R., Caramori, G., Bertolotti, G., & Bettoncelli, G. (2009). Quality of life in asthma and COPD: Is it measurable in primary care? Rassegna di Patologia dell'Apparato Respiratorio, 24(4), 220-226.

Quality of life in asthma and COPD : Is it measurable in primary care? / Carone, Maura; Arpinelli, Fabio; Pieretto, Andrea; Tosatto, Roberta; Caramori, Gaetano; Bertolotti, Giorgio; Bettoncelli, Germano.

In: Rassegna di Patologia dell'Apparato Respiratorio, Vol. 24, No. 4, 08.2009, p. 220-226.

Research output: Contribution to journalArticle

Carone, M, Arpinelli, F, Pieretto, A, Tosatto, R, Caramori, G, Bertolotti, G & Bettoncelli, G 2009, 'Quality of life in asthma and COPD: Is it measurable in primary care?', Rassegna di Patologia dell'Apparato Respiratorio, vol. 24, no. 4, pp. 220-226.
Carone, Maura ; Arpinelli, Fabio ; Pieretto, Andrea ; Tosatto, Roberta ; Caramori, Gaetano ; Bertolotti, Giorgio ; Bettoncelli, Germano. / Quality of life in asthma and COPD : Is it measurable in primary care?. In: Rassegna di Patologia dell'Apparato Respiratorio. 2009 ; Vol. 24, No. 4. pp. 220-226.
@article{f3fc40a156434baca46febb784b710b9,
title = "Quality of life in asthma and COPD: Is it measurable in primary care?",
abstract = "Background. An observational cross-sectional study under the acronym CORDIS (Chronic Obstructive Respiratory Disease - Italian Study), performed in primary care centers to evaluate the knowledge and the degree of control of physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD) by Italian General Practitioners (GPs). The study consisted of two phases, CORDIS-A and CORDIS-B. The CORDIS-B study included measurement of the quality of life (QoL) of physician-diagnosed asthma and COPD patients. Aim. Aim of the study was to evaluate the applicability of QoL assessment by means of the SF-12 Questionnaire in primary care in subjects with asthma or COPD. Secondary, to evaluate the impact of the two respiratory diseases on patients' QoL and to measure the correlation between patients' and GPs' opinion on patients' health status. Methods. Patients enrolled in the study were males and females aged more than 18 years, with a physician (GP or specialist) diagnosis of asthma and/or COPD and treated from at least 12 months with a short-term inhaled β 2-agonist, given alone or as component of a multiple therapy. Patients gave written informed consent to participate to the study and for personal data use. Each patient enrolled in the study privately filled in the QoL SF-12 questionnaire; both the patient and the GP gave independently the judgement of patient's health (Excellent, Very good, Good, Acceptable, Poor) and the two opinions were compared. Results. Complete QoL data were available for 11,642 subjects with a mean age of 57 ± 17 years and a prevalence of males of 55.3{\%}. The percentage of patients with asthma, COPD, and asthma plus COPD was 47.2{\%}, 29.2{\%} and 23.6{\%}, respectively. At least one concomitant disease was present in 67{\%} of patients. In terms of evaluation of patient's health status, a perfect concordance between the two types of evaluators was found in 54.6{\%}; the percentage increased up to 95{\%} when considering just one category of difference between the GP's and the patient's evaluation. As for the general Italian population, no substantial gender difference was found in our study for the SF-12 {"}Physical Component Summary{"} (PCS) and {"}Mental Component Summary{"} (MCS) mean scores. However, the CORDIS-B subjects showed more impaired health status in comparison to general population. Asthmatic patients showed better PCS and MCS scores in comparison to patients with COPD or asthma plus COPD (p <0.0001). Conclusions. This study shows that a) the SF-12 Questionnaire is a simple and useful tool to measure the QoL of patients with asthma and COPD in primary care; b) there was a very good agreement in the subjective evaluation of the patient's health status between GP and patient; c) mental/psychological component is underestimated both by GP and patient.",
keywords = "Asthma, COPD, Quality of life, SF-12 questionnaire",
author = "Maura Carone and Fabio Arpinelli and Andrea Pieretto and Roberta Tosatto and Gaetano Caramori and Giorgio Bertolotti and Germano Bettoncelli",
year = "2009",
month = "8",
language = "English",
volume = "24",
pages = "220--226",
journal = "Rassegna di Patologia dell'Apparato Respiratorio",
issn = "0033-9563",
publisher = "EdiAipo Scientifica s.c.a.r.l",
number = "4",

}

TY - JOUR

T1 - Quality of life in asthma and COPD

T2 - Is it measurable in primary care?

AU - Carone, Maura

AU - Arpinelli, Fabio

AU - Pieretto, Andrea

AU - Tosatto, Roberta

AU - Caramori, Gaetano

AU - Bertolotti, Giorgio

AU - Bettoncelli, Germano

PY - 2009/8

Y1 - 2009/8

N2 - Background. An observational cross-sectional study under the acronym CORDIS (Chronic Obstructive Respiratory Disease - Italian Study), performed in primary care centers to evaluate the knowledge and the degree of control of physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD) by Italian General Practitioners (GPs). The study consisted of two phases, CORDIS-A and CORDIS-B. The CORDIS-B study included measurement of the quality of life (QoL) of physician-diagnosed asthma and COPD patients. Aim. Aim of the study was to evaluate the applicability of QoL assessment by means of the SF-12 Questionnaire in primary care in subjects with asthma or COPD. Secondary, to evaluate the impact of the two respiratory diseases on patients' QoL and to measure the correlation between patients' and GPs' opinion on patients' health status. Methods. Patients enrolled in the study were males and females aged more than 18 years, with a physician (GP or specialist) diagnosis of asthma and/or COPD and treated from at least 12 months with a short-term inhaled β 2-agonist, given alone or as component of a multiple therapy. Patients gave written informed consent to participate to the study and for personal data use. Each patient enrolled in the study privately filled in the QoL SF-12 questionnaire; both the patient and the GP gave independently the judgement of patient's health (Excellent, Very good, Good, Acceptable, Poor) and the two opinions were compared. Results. Complete QoL data were available for 11,642 subjects with a mean age of 57 ± 17 years and a prevalence of males of 55.3%. The percentage of patients with asthma, COPD, and asthma plus COPD was 47.2%, 29.2% and 23.6%, respectively. At least one concomitant disease was present in 67% of patients. In terms of evaluation of patient's health status, a perfect concordance between the two types of evaluators was found in 54.6%; the percentage increased up to 95% when considering just one category of difference between the GP's and the patient's evaluation. As for the general Italian population, no substantial gender difference was found in our study for the SF-12 "Physical Component Summary" (PCS) and "Mental Component Summary" (MCS) mean scores. However, the CORDIS-B subjects showed more impaired health status in comparison to general population. Asthmatic patients showed better PCS and MCS scores in comparison to patients with COPD or asthma plus COPD (p <0.0001). Conclusions. This study shows that a) the SF-12 Questionnaire is a simple and useful tool to measure the QoL of patients with asthma and COPD in primary care; b) there was a very good agreement in the subjective evaluation of the patient's health status between GP and patient; c) mental/psychological component is underestimated both by GP and patient.

AB - Background. An observational cross-sectional study under the acronym CORDIS (Chronic Obstructive Respiratory Disease - Italian Study), performed in primary care centers to evaluate the knowledge and the degree of control of physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD) by Italian General Practitioners (GPs). The study consisted of two phases, CORDIS-A and CORDIS-B. The CORDIS-B study included measurement of the quality of life (QoL) of physician-diagnosed asthma and COPD patients. Aim. Aim of the study was to evaluate the applicability of QoL assessment by means of the SF-12 Questionnaire in primary care in subjects with asthma or COPD. Secondary, to evaluate the impact of the two respiratory diseases on patients' QoL and to measure the correlation between patients' and GPs' opinion on patients' health status. Methods. Patients enrolled in the study were males and females aged more than 18 years, with a physician (GP or specialist) diagnosis of asthma and/or COPD and treated from at least 12 months with a short-term inhaled β 2-agonist, given alone or as component of a multiple therapy. Patients gave written informed consent to participate to the study and for personal data use. Each patient enrolled in the study privately filled in the QoL SF-12 questionnaire; both the patient and the GP gave independently the judgement of patient's health (Excellent, Very good, Good, Acceptable, Poor) and the two opinions were compared. Results. Complete QoL data were available for 11,642 subjects with a mean age of 57 ± 17 years and a prevalence of males of 55.3%. The percentage of patients with asthma, COPD, and asthma plus COPD was 47.2%, 29.2% and 23.6%, respectively. At least one concomitant disease was present in 67% of patients. In terms of evaluation of patient's health status, a perfect concordance between the two types of evaluators was found in 54.6%; the percentage increased up to 95% when considering just one category of difference between the GP's and the patient's evaluation. As for the general Italian population, no substantial gender difference was found in our study for the SF-12 "Physical Component Summary" (PCS) and "Mental Component Summary" (MCS) mean scores. However, the CORDIS-B subjects showed more impaired health status in comparison to general population. Asthmatic patients showed better PCS and MCS scores in comparison to patients with COPD or asthma plus COPD (p <0.0001). Conclusions. This study shows that a) the SF-12 Questionnaire is a simple and useful tool to measure the QoL of patients with asthma and COPD in primary care; b) there was a very good agreement in the subjective evaluation of the patient's health status between GP and patient; c) mental/psychological component is underestimated both by GP and patient.

KW - Asthma

KW - COPD

KW - Quality of life

KW - SF-12 questionnaire

UR - http://www.scopus.com/inward/record.url?scp=70549086806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70549086806&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:70549086806

VL - 24

SP - 220

EP - 226

JO - Rassegna di Patologia dell'Apparato Respiratorio

JF - Rassegna di Patologia dell'Apparato Respiratorio

SN - 0033-9563

IS - 4

ER -